Scott Rocklage joined the prestigious 5AM Ventures in the year 2003 as one of the associates. As a result of his hard work and dedication, he rose to the position of a managing associate in the year 2004 and is based in Boston office. He brings to the table rich experience of over 30 years in the healthcare industry. At the same time, as a result of his leadership and strategic skills, he spearheaded the approval of three drugs by the FDA. During his career, he has held various prestigious roles in the healthcare field. Some of these include being the Chief Executive Officer and Chairman of Cubist Pharmaceuticals, Chief Executive Officer and President of Nycomed Salutar. At the same time, Scott also held the position of Board Chairman at Novira & Relypsa.
Today, he holds the position of Board of chairman for several companies including Pulmatrix, Epirus, Rennovia, Cidara, and Kinestral. He also previously served as the Chairman of companies such as Milkana, Semprus, and IIypsa, all of which were later acquired by other companies.
Scott Rocklage attended the University of California where he graduated with a B.S. (Chemistry). He later enrolled at MIT where he attained his honors in Chemistry. While at MIT, he was privileged to undertake research at the famous lab of Richard Schrock. Scott has more than 30 patents and 100 publications to his name.
In an interview conducted with ideamensch, Scott Rocklage reveals that the idea for his business resulted from the need to create solutions at an early stage in the healthcare industry. He continues to reveal that he does not have typical days as most of his days are different. Scott says that on one day, he could simply be handling business matters or gaining knowledge in a certain area of life.
Scott Rocklage says that working with respected entrepreneurs has helped him to bring ideas to life. This is made possible by the ability to create new drugs for humanity through having investors, scientists, or even physicians at his side. Interesting to note, Scott is time conscious and keen to prioritizing matters, a trait that makes him more productive as a person and entrepreneur. He further advises people to be bold when it comes to taking risks as it enables one to step out of their comfort zone and think big.